Depreciation in USD of Acumen Pharmaceuticals, Inc. from 2021 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Acumen Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2021 to Q1 2025.
  • Acumen Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2025 was $15K, a 6.25% decline year-over-year.
  • Acumen Pharmaceuticals, Inc. annual Depreciation for 2024 was $63K, a 3.28% increase from 2023.
  • Acumen Pharmaceuticals, Inc. annual Depreciation for 2023 was $61K, a 90.6% increase from 2022.
  • Acumen Pharmaceuticals, Inc. annual Depreciation for 2022 was $32K, a 700% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

Acumen Pharmaceuticals, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $15K -$1K -6.25% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q1 2024 $16K +$2K +14.3% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q1 2023 $14K +$10K +250% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $4K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09

Acumen Pharmaceuticals, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $63K +$2K +3.28% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-27
2023 $61K +$29K +90.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-27
2022 $32K +$28K +700% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $4K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.